AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 177 filers reported holding AMAG PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 2.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $963,000 | +9.3% | 102,468 | -11.0% | 0.00% | +100.0% |
Q2 2020 | $881,000 | +9.0% | 115,145 | -12.0% | 0.00% | -50.0% |
Q1 2020 | $808,000 | -44.8% | 130,779 | +8.8% | 0.00% | 0.0% |
Q4 2019 | $1,463,000 | +10.2% | 120,189 | +4.6% | 0.00% | 0.0% |
Q3 2019 | $1,327,000 | +21.4% | 114,850 | +5.0% | 0.00% | 0.0% |
Q2 2019 | $1,093,000 | -18.3% | 109,393 | +5.3% | 0.00% | -33.3% |
Q1 2019 | $1,338,000 | -14.3% | 103,866 | +1.1% | 0.00% | 0.0% |
Q4 2018 | $1,561,000 | -9.7% | 102,741 | +18.9% | 0.00% | 0.0% |
Q3 2018 | $1,729,000 | +4.2% | 86,436 | +1.5% | 0.00% | 0.0% |
Q2 2018 | $1,660,000 | -2.1% | 85,126 | +1.2% | 0.00% | -25.0% |
Q1 2018 | $1,695,000 | +51.6% | 84,101 | -0.3% | 0.00% | +100.0% |
Q4 2017 | $1,118,000 | -18.9% | 84,341 | +12.8% | 0.00% | -33.3% |
Q3 2017 | $1,379,000 | +2.3% | 74,765 | +2.1% | 0.00% | 0.0% |
Q2 2017 | $1,348,000 | -16.5% | 73,235 | +2.3% | 0.00% | -25.0% |
Q1 2017 | $1,615,000 | -12.3% | 71,610 | +35.3% | 0.00% | -20.0% |
Q4 2016 | $1,842,000 | +40.9% | 52,930 | -0.8% | 0.01% | +25.0% |
Q3 2016 | $1,307,000 | +4.6% | 53,339 | +2.2% | 0.00% | 0.0% |
Q2 2016 | $1,249,000 | +19.9% | 52,209 | +17.2% | 0.00% | +33.3% |
Q1 2016 | $1,042,000 | -7.9% | 44,537 | +18.9% | 0.00% | -25.0% |
Q4 2015 | $1,131,000 | -16.3% | 37,447 | +10.1% | 0.00% | -20.0% |
Q3 2015 | $1,352,000 | -37.7% | 34,027 | +8.3% | 0.01% | -28.6% |
Q2 2015 | $2,169,000 | +44.9% | 31,414 | +14.7% | 0.01% | +75.0% |
Q1 2015 | $1,497,000 | +45.9% | 27,379 | +13.8% | 0.00% | +33.3% |
Q4 2014 | $1,026,000 | +22.6% | 24,069 | -8.2% | 0.00% | 0.0% |
Q3 2014 | $837,000 | +53.0% | 26,219 | -0.6% | 0.00% | +50.0% |
Q2 2014 | $547,000 | +19.7% | 26,389 | +11.6% | 0.00% | +100.0% |
Q1 2014 | $457,000 | -26.8% | 23,640 | -8.1% | 0.00% | -50.0% |
Q4 2013 | $624,000 | +13.0% | 25,720 | 0.0% | 0.00% | 0.0% |
Q3 2013 | $552,000 | -4.3% | 25,720 | -0.7% | 0.00% | 0.0% |
Q2 2013 | $577,000 | – | 25,914 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HUNTINGTON NATIONAL BANK | 1 | $14 | 0.00% |